It was reported that FAN at concentrations from 1 to 3 mg/kg could significantly attenuate the tumor volume and weight in mice by suppressing the PI3K/AKT/mTOR pathway [50], suggesting it is likely feasible to use FAN for in vivo application. The gene discussed is AKT1; the disease is neoplasm.